Nomura Holdings’s TG Therapeutics TGTX Stock Holding History

Nomura Holdings’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75M	Buy	+50,000	New	+$2.05M	﹤0.01%	995

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Nomura Holdings's TGTX Position: Q2 2024 in Review

Nomura Holdings sold out of TG Therapeutics (TGTX) in Q2 2024, closing a stake of 42,520 shares — an estimated $647K sold.

Nomura Holdings first reported a position in TGTX in Q2 2020 and held it in 2 quarters. The position peaked at $647K in Q1 2024. 259 funds tracked by Wall St. Rank hold TGTX as of Q2 2024.

Nomura Holdings reported no remaining TG Therapeutics position as of Q2 2024 after selling out during the quarter.
Nomura Holdings sold 42,520 TG Therapeutics shares in Q2 2024, an estimated $647K.
Nomura Holdings first reported a position in TG Therapeutics in Q2 2020 and held it in 2 quarters.
Nomura Holdings's TG Therapeutics position peaked at $647K in Q1 2024.
259 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2024.

Based on Nomura Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.